Custom Health Holdings Inc. (TSX:CHLT) closed a public offering of 2,088,514 units at C$4.95 per unit, raising gross proceeds of C$10,338,144.30, according to a press release issued today.
Each unit consists of one common share and one warrant. Each warrant lets the holder buy one common share at C$5.90 for 60 months. Stifel Nicolaus Canada Inc. served as lead agent and sole bookrunner.
The units were offered across Canada except Quebec under a prospectus supplement dated November 11, 2026, filed under a base shelf prospectus dated November 5, 2026. The offering also included a private placement to accredited investors and qualified institutional buyers in the United States.
Shane Bishop, the company's Chief Executive Officer and director, bought 282,830 units for C$1,400,008.50. The company said this was a related party transaction under Multilateral Instrument 61-101. It said the company was exempt from formal valuation and minority shareholder approval requirements because the transaction value did not exceed 25% of its market capitalization.
The company said net proceeds will fund payments for previously announced acquisitions and related transaction costs, planned debt repayments, general and administrative expenses, and working capital.
The common shares have been listed on the Toronto Stock Exchange. The common shares underlying the warrants and agent warrants received conditional TSX listing approval. The company said it will seek to list the warrants on the TSX later, but gave no guarantee on timing or approval.
Custom Health describes itself as a digital health company that provides medication management services through in-home dispensing technology, remote monitoring, and pharmacist-led care.